Background And Purpose: The Heart of Glass (HEG) receptor binds KRIT1 and functions with KRIT1, CCM2, and PDCD10 in a common signaling pathway required for heart and vascular development. Mutations in KRIT1, CCM2, and PDCD10 also underlie human cerebral cavernous malformation (CCM) and postnatal loss of these genes in the mouse endothelium results in rapid CCM formation. Here, we test the role of HEG in CCM formation in mice and in humans.
Methods: We constitutively or conditionally deleted Heg and Ccm2 genes in genetically modified mice. Mouse embryos, brain, and retina tissues were analyzed to assess CCM lesion formation.
Results: In postnatal mice, CCMs form with Ccm2-/- but not with Heg-/- or Heg-/-;Ccm2+/- endothelial cells. Consistent with these findings, human patients with CCM who lack exonic mutations in KRIT1, CCM2, or PDCD10 do not have mutations in HEG.
Conclusions: These findings suggest that the HEG-CCM signaling functions during cardiovascular development and growth, whereas CCMs arise because of loss of HEG-independent CCM signaling in the endothelium of the central nervous system after birth.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006321 | PMC |
| http://dx.doi.org/10.1161/STROKEAHA.114.004809 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations.
EMBO Mol Med
November 2024
Institute of Biochemistry and Biology, Potsdam University, D-14476, Potsdam, Germany.
Cerebral cavernous malformations (CCMs) are anomalies of the cerebral vasculature. Loss of the CCM proteins CCM1/KRIT1, CCM2, or CCM3/PDCD10 trigger a MAPK-Krüppel-like factor 2 (KLF2) signaling cascade, which induces a pathophysiological pattern of gene expression. The downstream target genes that are activated by KLF2 are mostly unknown.
View Article and Find Full Text PDFA renaissance of cerebral cavernous malformation proteins in vascular physiology.
Nat Cardiovasc Res
July 2024
Wallace H. Coulter Department of Biomedical Engineering, Emory University & Georgia Tech, Atlanta, GA, USA.
Comprehensive analysis of Novel mutations in CCM1/KRIT1 and CCM2/MGC4607 and their clinical implications in Cerebral Cavernous malformations.
J Stroke Cerebrovasc Dis
November 2024
Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Departamento de Neurocirurgia, Rio de Janeiro RJ, Brasil.
Article Synopsis
- Cerebral Cavernous Malformations (CCM) is a genetic disorder affecting a small percentage of the population and is characterized by vascular irregularities in the brain and spinal cord; the study discovered two new mutations that disrupt important protein functions.* -
- The research analyzed a group of Brazilian CCM patients to identify genetic variations and their potential effects on disease progression, using a combination of genetic sequencing and structural analysis tools.* -
- The findings revealed multiple mutations, demonstrated significant changes in protein structure potentially linked to pathogenesis, and highlighted a wide range of symptoms among patients, although no significant differences were found in clinical characteristics based on the newly identified mutations.*
Concurrent multiple cerebral cavernous malformations and cauda equina paraganglioma: illustrative case.
J Neurosurg Case Lessons
August 2024
Departments of Neurosurgery, St George Hospital, Kogarah, New South Wales, Australia.
Background: Cauda equina neuroendocrine tumors (CENETs), previously known as cauda equina paragangliomas, and multiple cerebral cavernous malformations (CCMs) are uncommon conditions affecting the central nervous system. To the authors' knowledge, they have not been reported in the same patient.
Observations: The authors present the case of a 45-year-old male with CENET and concurrent incidental MRI findings of multiple CCMs.
KRIT1 in vascular biology and beyond.
Biosci Rep
July 2024
Department of Pharmacology and Physiology, University of Rochester, Rochester, NY, U.S.A.
KRIT1 is a 75 kDa scaffolding protein which regulates endothelial cell phenotype by limiting the response to inflammatory stimuli and maintaining a quiescent and stable endothelial barrier. Loss-of-function mutations in KRIT1 lead to the development of cerebral cavernous malformations (CCM), a disease marked by the formation of abnormal blood vessels which exhibit a loss of barrier function, increased endothelial proliferation, and altered gene expression. While many advances have been made in our understanding of how KRIT1, and the functionally related proteins CCM2 and PDCD10, contribute to the regulation of blood vessels and the vascular barrier, some important open questions remain.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!